# A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat

> **NCT00647829** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 197 (actual)

## Conditions studied

- Pharyngitis

## Interventions

- **DRUG:** valdecoxib
- **DRUG:** valdecoxib
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00647829
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02
- **Primary completion:** —
- **Final completion:** 2003-12
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2008-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647829, "A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00647829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*